Phospholipase (e.g. PLA)

Signaling Pathway Map

Research Area

  • Inhibitory Selectivity
  • Solubility
Catalog No. Product Name Solubility(25°C)
Water DMSO Alcohol
S1110 Varespladib (LY315920) <1 mg/mL 76 mg/mL <1 mg/mL
S4089 Halobetasol Propionate <1 mg/mL 97 mg/mL 38 mg/mL
S4255 Quinacrine 2HCl 53 mg/mL 14 mg/mL 28 mg/mL
S8011 U73122 <1 mg/mL 0.01 mg/mL <1 mg/mL
S2390 Polydatin <1 mg/mL 78 mg/mL <1 mg/mL
S7520 Darapladib (SB-480848) <1 mg/mL 100 mg/mL 100 mg/mL
S2364 Tanshinone I <1 mg/mL 23 mg/mL <1 mg/mL
S4107 Clofazimine <1 mg/mL 5 mg/mL <1 mg/mL
Catalog No. Information Product Use Citations Product Validations

Varespladib (LY315920)

Varespladib (LY315920) is a potent and selective human non-pancreatic secretory phospholipase A2 (hnsPLA) inhibitor with IC50 of 7 nM. Phase 3.


Halobetasol Propionate

Halobetasol Propionate is an anti-inflammatory and a dermatologic agent commonly used to treat psoriasis.


Quinacrine 2HCl

Quinacrine 2HCl is a lipophilic cationic drug with multiple actions that is commonly used as an anti-protozoal agent. Quinacrine is an effective phospholipase A2 inhibitor.



U73122 is a potent phospholipase C (PLC) inhibitor, which reduces agonist-induced Ca2+ increases in platelets and PMN.



Polydatin is a crystal component extracted from the root stem of perennial herbage Polygonum Cuspidatum Zucc.


Darapladib (SB-480848)

Darapladib (SB-480848) is a reversible lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor with IC50 of 0.25 nM. Phase 3.


Tanshinone I

Tanshinone I, an active principle isolated from Salvia miltiorrhiza (Danshen), is structurally similar to tanshinone IIA and may possess similar cytotoxic effects on tumor cells.



Clofazimine is a rhimophenazine dye, originally developed for the treatment of tuberculosis, it has both antimicrobial and antiinflammatory activity, postulated mechanisms of action include intercalation of clofazimine with bacterial DNA and increasing levels of cellular phospholipase A2.